CD274 and neoplasm: Thus, despite continued expression of PD-L1 by the tumour cells (see below), the absence of PD-L1 expression by the tumour infiltrating host cells enhanced anti-tumour immunity, albeit not as well as the administration of anti-PD-L1 antibody (Fig. 1d).